Related Experiment Video

Updated: May 1, 2026

Creation of Patient-Specific Silicone Cardiac Models with Applications in Pre-surgical Plans and Hands-on Training
09:15

Creation of Patient-Specific Silicone Cardiac Models with Applications in Pre-surgical Plans and Hands-on Training

Published on: February 10, 2022

4.9K

Challenges facing early career academic cardiologists

Carl W Tong1, Tariq Ahmad2, Evan L Brittain3

  • 1Department of Medical Physiology and Department of Medicine/Cardiology Division, Texas A&M University Health Science Center-Baylor Scott & White Healthcare, Temple, Texas.

Journal of the American College of Cardiology
|April 8, 2014
PubMed

Insights

Early career academic cardiologists face significant challenges. This white paper defines these issues, identifies obstacles, and proposes solutions to support the future of cardiovascular medicine.

Area of Science:

  • Cardiovascular Medicine
  • Medical Education
  • Physician Workforce Development

Background:

  • Early career academic cardiologists encounter numerous challenges impacting their career progression.
  • The American College of Cardiology (ACC) recognizes the need to address these issues to sustain the field.

Purpose of the Study:

  • To define categories of early career academic cardiologists.
  • To identify general and specific challenges faced by these professionals.
  • To propose actionable solutions and recommendations.

Main Methods:

  • A white paper developed by early career professionals and ACC senior leadership.
  • Analysis of challenges across different early career cardiologist categories.
  • Inclusion of survey data from current ACC early career members.
  • Examination of National Institute of Health/National Heart Lung and Blood Institute grant funding failures for physician-scientists.

Main Results:

  • Categorization of early career academic cardiologists.
  • Identification of key obstacles and challenges through surveys and expert consensus.
  • Analysis of funding disparities for physician-scientists.
  • Development of potential solutions and a call to action.

Conclusions:

  • Addressing the challenges faced by early career academic cardiologists is critical for the future of cardiovascular medicine.
  • Implementing proposed solutions can improve career sustainability and research funding.
  • A collaborative approach involving early career professionals and leadership is essential for progress.

Keywords:
academic medical centerclinician-educatorearly career academic cardiologistphysician-scientist

More Related Videos

Slicing and Culturing Pig Hearts under Physiological Conditions07:54

Slicing and Culturing Pig Hearts under Physiological Conditions

Published on: March 20, 2020

16.9K
Author Spotlight: Enhancing Graft Viability Assessment Through Quantitative Metrics and Innovative Reservoir Systems08:49

Author Spotlight: Enhancing Graft Viability Assessment Through Quantitative Metrics and Innovative Reservoir Systems

Published on: August 2, 2024

1.4K

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
753
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
790
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
805
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.8K
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
952
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
444